During the past decade, Hospital do Meixoeiro conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 7 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital do Meixoeiro" #1 sponsor was "PETHEMA Foundation" with 4 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored and "Hospital de Meixoeiro" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital do Meixoeiro" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Complejo Hospitalario Universitario de Vigo" with 1 trials as a collaborator, "Dynamic Solutions" with 1 trials as a collaborator and "Fondo de Investigacion Sanitaria" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Hospital do Meixoeiro" are "Systemic Lupus Erythematosus" (4 trials), "Angioplasty, Transluminal, Percutaneous Coronary" (2 trials), "Arthritis, Psoriatic" (2 trials), "Atrial Fibrillation" (2 trials) and "Myocardial Infarction" (2 trials). Many other conditions were trialed in "Hospital do Meixoeiro" in a lesser frequency.

Most popular intervention types in "Hospital do Meixoeiro" are "Drug" (23 trials), "Other" (7 trials), "Device" (5 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Baricitinib" (3 trials), "Acetaminophen/Paracetamol" (1 trials), "Adalimumab (HUMIRA®)" (1 trials) and "Ambulatory blood pressure monitoring" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital do Meixoeiro" are 37 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital do Meixoeiro". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Hospital do Meixoeiro, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital do Meixoeiro, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 3 trials that are defined as “Not Applicable".